Selecta Biosciences
(NASDAQ) SELB
Selecta Biosciences Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$2.80M
Net Income (TTM)
$130.30M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
SELB News
3 Top Healthcare Stocks Under $5
SELB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Selecta Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
75
CEO
Carsten Brunn, PhD
Headquarters
Watertown, MA 02472, US
SELB Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
-47%
Return on Equity
3%
Return on Capital
0%
Return on Assets
-44%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$0.00
EBITDA
$0.00
Operating Cash Flow
$73.94M
Capital Expenditure
$5.45M
Free Cash Flow
$79.39M
Cash & ST Invst.
$125.14M
Total Debt
$12.68M
Selecta Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$947.00K
-95.5%
Gross Profit
$0.00
-100.0%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
64
N/A
Net Income
$92.58M
-195.9%
EBITDA
$21.81M
+154.4%
Quarterly Fundamentals
Net Cash
$112.46M
-43.4%
Accounts Receivable
$1.11M
+27.9%
Inventory
$0.00
N/A
Long Term Debt
$8.53M
-23.4%
Short Term Debt
$4.15M
+45.6%
Return on Assets
-43.96%
N/A
Return on Invested Capital
0.00%
N/A
Free Cash Flow
$18.20M
-283.2%
Operating Cash Flow
$17.71M
-521.6%